Canopy Growth Corp.: Does This Stock Belong in Your Portfolio?

Canopy Growth Corp. (TSX:WEED) is a leader in the emerging medical marijuana industry, but can the company maintain its rapid growth?

| More on:

The cannabis industry has become one of the most discussed industries in the past year. With the first gram of recreational marijuana expected to be sold in early 2018, some analysts have estimated the recreation market to be worth close to $6 billion in Canada. Although there are high expectations for the future of this market, there is still a lot of work to be done by the government before legalization occurs.

In the meantime, Canopy Growth Corp. (TSX:WEED) has established itself as the clear leader in the industry and has been aggressively expanding its operations. With no signs of slowing down in this emerging market, Canopy should continue to dominate the Canadian market and expand its operations internationally.

Here are two reasons why Canopy can maintain its status as the industry leader.

No competition from the south

Although marijuana has been legalized for recreational use in eight states, it’s still illegal at the federal level in the U.S. Therefore, American cannabis companies are limited to selling cannabis within state borders and can’t expand their operations to a national level.

With Trump’s intention to keep cannabis illegal on a federal level, it creates an opportunity for Canadian companies to penetrate international markets before the U.S. Canopy has already begun to take advantage and has been shipping its products to countries such as Germany and Brazil.

With its first-mover advantage and well-established operations, Canopy is poised to become a globally recognized cannabis producer.

Acquisition of Mettrum Health

Canopy has done a great job creating a company brand through its subsidiary Tweed, attracting customers with medical marijuana licenses, and priming itself for the recreational market. However, one of its weaknesses was targeting doctors and informing them of the benefits of medical marijuana, so they can prescribe their products. Canopy addressed this weakness by acquiring Mettrum Health.

Mettrum’s strategy was focusing on doctors rather than patients, which allowed it to become the second-largest cannabis producer in Canada before the takeover. Through the acquisition, Canopy has essentially become the preferred producer for both doctors and patients, which positions the company well in the medical and recreational market.

Foolish bottom line

The cannabis industry is still highly speculative, and all of the pot stocks’ current valuations do not align with historical fundamental analysis. However, in the past few months, Canopy’s stock price has stabilized from its extreme volatility in November 2016.

If you’re keen on gaining exposure to this industry, you’re better off acquiring shares in established and profitable companies such as Canopy. With much uncertainty surrounding these stocks, it’s important to make sure that any acquisition is only a small portion of your portfolio.

Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Colin Beck has no position in any stocks mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »